Eloralintide, a selective, long‐acting amylin receptor agonist for treatment of obesity: Phase 1 proof of concept - Bhattachar - 2026 - Diabetes, Obesity and Metabolism US$ 26.16 Min. order: 1 piece ★★★★★ 4.2 (170 reviews) Sold : Login>>
Cagrilintide is a long-acting amylin analog that regulates appetite, gastric emptying, and glucagon secretion to treat obesity and related metabolic disorders. There are 2 pathways cagrilintide works: US$ 26.71 Min. order: 1 piece ★★★★★ 4.3 (258 reviews) Sold : Login>>
Incretin hormone agonists: Current and emerging pharmacotherapy for obesity management - Alhomoud - 2024 - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy US$ 21.50 Min. order: 1 piece ★★★★★ 4.5 (83 reviews) Sold : Login>>
Cagrilintide Peptide Therapy: A New Era in Appetite Control and Weight – Revolution Health & Wellness US$ 23.69 Min. order: 1 piece ★★★★★ 4.9 (232 reviews) Sold : Login>>
BPC-157 Pure Immediate Release, 30 Capsules US$ 23.33 Min. order: 1 piece ★★★★★ 4.0 (275 reviews) Sold : Login>>
Novo's Phase 3 CagriSema results disappoint analysts, sending stock tumbling - MM+M US$ 21.29 Min. order: 1 piece ★★★★★ 5.0 (22 reviews) Sold : Login>>